Literature DB >> 22891703

Ca++/CaMKII switches nociceptor-sensitizing stimuli into desensitizing stimuli.

Tim Hucho1, Vanessa Suckow, Elizabeth K Joseph, Julia Kuhn, Jan Schmoranzer, Olayinka A Dina, Xiaojie Chen, Matthias Karst, Michael Bernateck, Jon D Levine, Hans-Hilger Ropers.   

Abstract

Many extracellular factors sensitize nociceptors. Often they act simultaneously and/or sequentially on nociceptive neurons. We investigated if stimulation of the protein kinase C epsilon (PKCε) signaling pathway influences the signaling of a subsequent sensitizing stimulus. Central in activation of PKCs is their transient translocation to cellular membranes. We found in cultured nociceptive neurons that only a first stimulation of the PKCε signaling pathway resulted in PKCε translocation. We identified a novel inhibitory cascade to branch off upstream of PKCε, but downstream of Epac via IP3-induced calcium release. This signaling branch actively inhibited subsequent translocation and even attenuated ongoing translocation. A second 'sensitizing' stimulus was rerouted from the sensitizing to the inhibitory branch of the signaling cascade. Central for the rerouting was cytoplasmic calcium increase and CaMKII activation. Accordingly, in behavioral experiments, activation of calcium stores switched sensitizing substances into desensitizing substances in a CaMKII-dependent manner. This mechanism was also observed by in vivo C-fiber electrophysiology corroborating the peripheral location of the switch. Thus, we conclude that the net effect of signaling in nociceptors is defined by the context of the individual cell's signaling history.
© 2012 The Authors Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891703     DOI: 10.1111/j.1471-4159.2012.07920.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  [1 + 1 = 0. Reprogramming of nociceptors].

Authors:  T Hucho
Journal:  Schmerz       Date:  2014-12       Impact factor: 1.107

2.  Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.

Authors:  Ying He; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

3.  Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.

Authors:  Saikat Chakraborty; Vincent Elvezio; Martin Kaczocha; Mario Rebecchi; Michelino Puopolo
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

Review 4.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

5.  Dopamine modulation of transient receptor potential vanilloid type 1 (TRPV1) receptor in dorsal root ganglia neurons.

Authors:  Saikat Chakraborty; Mario Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Physiol       Date:  2016-01-06       Impact factor: 5.182

Review 6.  Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels.

Authors:  Daniel C Cook; Peter A Goldstein
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

7.  Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion Injury.

Authors:  Carl M Hurt; Yao Lu; Creed M Stary; Honit Piplani; Bryce A Small; Travis J Urban; Nir Qvit; Garrett J Gross; Daria Mochly-Rosen; Eric R Gross
Journal:  J Am Heart Assoc       Date:  2016-09-26       Impact factor: 5.501

8.  Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia.

Authors:  Ben-Long Liu; Qi-Lai Cao; Xin Zhao; Hui-Zhu Liu; Yu-Qiu Zhang
Journal:  JCI Insight       Date:  2020-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.